PTC Therapeutics (PTCT) announced that its partner, Akcea Therapeutics, affiliate of Ionis Pharmaceuticals (IONS), received a positive opinion for WAYLIVRA by the Committee for Medicinal Products for Human Use of the European Medicines Agency. PTC plans to initiate activities to bring WAYLIVRA to patients in Latin America following European Commission ratification.
https://thefly.com/landingPageNews.php?id=2873605
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.